II BRAZILIAN CONSENSUS ON GASTRIC CANCER BY THE BRAZILIAN GASTRIC CANCER ASSOCIATION

Background: Since the publication of the first Brazilian Consensus on Gastric Cancer (GC) in 2012 carried out by the Brazilian Gastric Cancer Association, new concepts on diagnosis, staging, treatment and follow-up have been incorporated.

Aim: This new consensus is to promote an update to professionals working in the fight against GC and to provide guidelines for the management of patients with this condition.

Methods: Fifty-nine experts answered 67 statements regarding the diagnosis, staging, treatment and prognosis of GC with five possible alternatives: 1) fully agree; 2) partially agree; 3) undecided; 4) disagree and 5) strongly disagree A consensus was adopted when at least 80% of the sum of the answers "fully agree" and "partially agree" was reached. This article presents only the responses of the participating experts. Comments on each statement, as well as a literature review, will be presented in future publications.

Results: Of the 67 statements, there was consensus in 50 (74%). In 10 declarations, there was 100% agreement.

Conclusion: The gastric cancer treatment has evolved considerably in recent years. This consensus gathers consolidated principles in the last decades, new knowledge acquired recently, as well as promising perspectives on the management of this disease.

Citing Articles

RATIO OF METASTATIC LYMPH NODES VS. RESECTED LYMPH NODES (N-RATIO) HAS PROGNOSTIC IMPLICATIONS IN GASTRIC CANCER.

Porto B, Pereira M, Ramos M, Dias A, Lopasso F, Carneiro DAlbuquerque L Arq Bras Cir Dig. 2024; 37:e1824.

PMID: 39319897 PMC: 11419286. DOI: 10.1590/0102-6720202400031e1824.

THE VALUE OF PREOPERATIVE PROGNOSTIC NUTRITIONAL INDEX IN GASTRIC CANCER AFTER CURATIVE RESECTION.

Tustumi F, Pereira M, Lisak A, Ramos M, Ribeiro Junior U, Dias A Arq Bras Cir Dig. 2024; 37:e1805.

PMID: 38896701 PMC: 11182628. DOI: 10.1590/0102-6720202400012e1805.

Gastric cancer: an overview.

Carmo G, Cavalcante R, Aquino T Rev Assoc Med Bras (1992). 2024; 70(suppl 1):e2024S116.

PMID: 38865536 PMC: 11164282. DOI: 10.1590/1806-9282.2024S116.

Assessment of programmed death-ligand 1 expression in primary tumors and paired lymph node metastases of gastric adenocarcinoma.

Cacao Coimbra B, Pereira M, Cardili L, Alves V, de Mello E, Ribeiro Jr U World J Gastrointest Oncol. 2024; 16(3):883-893.

PMID: 38577458 PMC: 10989385. DOI: 10.4251/wjgo.v16.i3.883.

INTRAPERITONEAL CHEMOTHERAPY FOR GASTRIC CANCER WITH PERITONEAL CARCINOMATOSIS: STUDY PROTOCOL OF A PHASE II TRIAL.

Ramos M, Pereira M, Charruf A, Victor C, Gregorio J, Alban L Arq Bras Cir Dig. 2023; 36:e1744.

PMID: 37466566 PMC: 10356002. DOI: 10.1590/0102-672020230026e1744.

References

. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2020; 24(1):1-21. PMC: 7790804. DOI: 10.1007/s10120-020-01042-y. View

Moore M, Eser S, Igisinov N, Igisinov S, Mohagheghi M, Mousavi-Jarrahi A . Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pac J Cancer Prev. 2010; 11 Suppl 2:17-32. View

Ajani J, DAmico T, Almhanna K, Bentrem D, Chao J, Das P . Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016; 14(10):1286-1312. DOI: 10.6004/jnccn.2016.0137. View

Norero E, Quezada J, Cerda J, Ceroni M, Martinez C, Mejia R . RISK FACTORS FOR SEVERE POSTOPERATIVE COMPLICATIONS AFTER GASTRECTOMY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION CANCERS. Arq Bras Cir Dig. 2019; 32(4):e1473. PMC: 6918748. DOI: 10.1590/0102-672020190001e1473. View

Amorim C, Moreira J, Rial L, Carneiro A, Fogaca H, Elia C . Ecological study of gastric cancer in Brazil: geographic and time trend analysis. World J Gastroenterol. 2014; 20(17):5036-44. PMC: 4009538. DOI: 10.3748/wjg.v20.i17.5036. View

Zaanan A, Bouche O, Benhaim L, Buecher B, Chapelle N, Dubreuil O . Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis. 2018; 50(8):768-779. DOI: 10.1016/j.dld.2018.04.025. View

Zilberstein B, Malheiros C, Lourenco L, Kassab P, Jacob C, Weston A . Brazilian consensus in gastric cancer: guidelines for gastric cancer in Brazil. Arq Bras Cir Dig. 2013; 26(1):2-6. DOI: 10.1590/s0102-67202013000100002. View

. [Developing a methodology for drawing up guidelines on best medical practices. (Recommendation (2001)13 and explanatory memorandum)]. Z Arztl Fortbild Qualitatssich. 2003; 96 Suppl 3:5-59. View

Peduk S, Dincer M, Tatar C, Ozer B, Kocakusak A, Citlak G . THE ROLE OF SERUM CK-18, MMP-9 AND TIPM-1 LEVELS IN PREDICTING R0 RESECTION IN PATIENTS WITH GASTRIC CANCER. Arq Bras Cir Dig. 2018; 31(4):e1401. PMC: 6284391. DOI: 10.1590/0102-672020180001e1401. View

10.

Lee J, Kim J, Jung H, Kim J, Jeong W, Jeon T . Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer. 2014; 14(2):87-104. PMC: 4105383. DOI: 10.5230/jgc.2014.14.2.87. View

11.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

12.

Barchi L, Gama-Rodrigues J, Carvalho F, Barchi M, Oliveira O, Carneiro M . Cystic gastric stromal tumor negative C-Kit. Arq Bras Cir Dig. 2013; 25(4):300-2. DOI: 10.1590/s0102-67202012000400018. View

13.

Smyth E, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D . Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016; 27(suppl 5):v38-v49. DOI: 10.1093/annonc/mdw350. View

14.

Sano T, Coit D, Kim H, Roviello F, Kassab P, Wittekind C . Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 2016; 20(2):217-225. PMC: 4992472. DOI: 10.1007/s10120-016-0601-9. View

15.

Kulig J, Wallner G, Drews M, Fraczek M, Jeziorski A, Kielan W . Polish Consensus on Treatment of Gastric Cancer; update 2017. Pol Przegl Chir. 2017; 89(5):59-73. DOI: 10.5604/01.3001.0010.5413. View

16.

Ramos M, Pereira M, Charruf A, Dias A, de Castria T, Barchi L . CONVERSION THERAPY FOR GASTRIC CANCER: EXPANDING THE TREATMENT POSSIBILITIES. Arq Bras Cir Dig. 2019; 32(2):e1435. PMC: 6488271. DOI: 10.1590/0102-672020190001e1435. View

17.

Figueroa-Giralt M, Csendes A, Carrillo K, Danilla S, Lanzarini E, Braghetto I . INTRODUCTION OF THE NEW LYMPHOPARIETAL INDEX FOR GASTRIC CANCER PATIENTS. Arq Bras Cir Dig. 2019; 32(2):e1441. PMC: 6713052. DOI: 10.1590/0102-672020190001e1441. View

18.

De Manzoni G, Marrelli D, Baiocchi G, Morgagni P, Saragoni L, Degiuli M . The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer. 2016; 20(1):20-30. DOI: 10.1007/s10120-016-0615-3. View

19.

Baiocchi G, Dugo D, Coit D, Hardwick R, Kassab P, Nashimoto A . Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference. Gastric Cancer. 2015; 19(1):15-20. PMC: 4890702. DOI: 10.1007/s10120-015-0513-0. View

20.

Dias A, Camargo Azevedo B, Alban L, Yagi O, Ramos M, Jacob C . GASTRIC NEUROENDOCRINE TUMOR: REVIEW AND UPDATE. Arq Bras Cir Dig. 2017; 30(2):150-154. PMC: 5543797. DOI: 10.1590/0102-6720201700020016. View